Pharmaceutical Compositions Comprising Soluble CD137
AssigneeUniversity of Cincinnati
InventorsWilliam Ridgway, David Erwin Adams, Kritika Kachapati
Life of this patent
Estimating the term…
Abstract
A method for treating or preventing a T-cell-mediated autoimmune disease is provided herein, the method including administering to a mammal in need thereof a therapeutically effective amount of soluble CD137 or CD137pos regulatory T cells. Also provided are pharmaceutical compositions for treating or preventing T-cell-mediated autoimmune diseases, the pharmaceutical compositions including a therapeutically effective amount of soluble CD137 or CD137pos regulatory T cells and a pharmaceutically-acceptable carrier.
Claims6
1-12. (canceled)
A pharmaceutical composition for the treatment of a T-cell-mediated autoimmune disease comprising:
- a therapeutically effective amount of soluble CD137;
- and
- a pharmaceutically-acceptable carrier.
17-20. (canceled)
Dependencies are inferred from the claim text.